United States — Food and Drug Administration & Rosen Law Firm
21 shared events · Importance 3 · Last updated Aug 22, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Disc Medicine, Inc. regarding its bitopertin program, citing uncertainties in the new drug application.
Rosen Law Firm: Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. on behalf of its shareholders, seeking to recover investor losses.
Apr 29, 2026 · 68 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to ImmunityBio regarding misleading efficacy claims made by Patrick Soon-Shiong about Anktiva, which triggered the stock price drop and subsequent lawsuits.
Rosen Law Firm: Rosen Law Firm is actively filing and encouraging investors to join a securities class action lawsuit against ImmunityBio, seeking compensation for investors who suffered losses.
Apr 02, 2026 · 132 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs related to Zoetis' Bedinvetmab, contributing to its weakening adoption.
Rosen Law Firm: Rosen Law Firm is a global investor rights law firm that reminds purchasers of Zoetis securities about the lead plaintiff deadline for the class action lawsuit.
May 18, 2026 · 316 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Aldeyra Therapeutics, citing a lack of substantial evidence for the efficacy of reproxalap, which triggered the stock price drop and subsequent lawsuits.
Rosen Law Firm: Rosen Law Firm is a global investor rights law firm that reminds purchasers of Aldeyra Therapeutics securities about the lead plaintiff deadline in the securities class action it first filed.
Apr 24, 2026 · 80 articles
Regulatory
United States — Food and Drug Administration: Regulator whose briefing documents and advisory committee vote triggered the stock collapse and legal actions.
Rosen Law Firm: Filed a class action lawsuit against Capricor.
Jul 27, 2026 · 293 articles
Regulatory
United States — Food and Drug Administration: The FDA issued safety warnings about neurological complications in dogs from Zoetis' Librela, which contributed to the alleged decline in prescriptions.
Rosen Law Firm: Rosen Law Firm is one of the law firms representing investors in the class action, reminding shareholders of the lead plaintiff deadline.
Jun 26, 2026 · 34 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Rosen Law Firm interact across events, view sentiment trends, and discover connected entities.
Open Dashboard